Featured in MedTech Intelligence

October 14, 2019

Highlighting the rise of liver disease, including non-alcoholic fatty liver disease (NAFLD), this article describes how a growing number of healthcare providers are adopting FibroScan®, a non-invasive technology to examine a patient’s liver health at point of care.

Read the full article here.